ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of Napabucasin (BBI-608) in Combination With FOLFIRI in Adult Patients With Previously Treated Metastatic Colorectal Cancer

ClinicalTrials.gov ID: NCT02753127

Public ClinicalTrials.gov record NCT02753127. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 14, 2026, 6:58 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Study of BBI-608 in Combination With 5-Fluorouracil, Leucovorin, Irinotecan (FOLFIRI) in Adult Patients With Previously Treated Metastatic Colorectal Cancer (CRC).

Study identification

NCT ID
NCT02753127
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sumitomo Pharma America, Inc.
Industry
Enrollment
1,253 participants

Conditions and interventions

Interventions

  • Bevacizumab Drug
  • Fluorouracil Drug
  • Irinotecan Drug
  • Leucovorin Drug
  • Napabucasin Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2016
Primary completion
Apr 27, 2020
Completion
May 11, 2021
Last update posted
Nov 14, 2023

2016 – 2021

United States locations

U.S. sites
74
U.S. states
29
U.S. cities
69
Facility City State ZIP Site status
Alabama Oncology Birmingham Alabama 35223
Mayo Clinic Arizona Phoenix Arizona 85054
Arizona Oncology Associates, PC - HOPE Tucson Arizona 85771
Comprehensive Blood and Cancer Center Bakersfield California 93309
City of Hope- Comprehensive Care Center Duarte California 91010
University of California-San Diego/Moores UCSD Cancer Center La Jolla California 92093
Los Angeles Hematology Oncology Medical Group Los Angeles California 90017
USC Norris Comprehensive Cancer Center Los Angeles California 90033
UCLA Hematology Oncology Santa Monica Santa Monica California 90404
St. Joseph Heritage Healthcare Santa Rosa California 95405
Rocky Mountain Cancer Centers Denver Colorado 80218
St Mary's Hospital & Regional Med Center Grand Junction Colorado 81501
Medical Oncology Hematology Consultants, PA Newark Delaware 19713
Florida Cancer Specialists & Research Institute Fort Myers Fort Myers Florida 33901
Memorial Cancer Institute at Memorial Hospital Hollywood Florida 33021
Baptist Health Medical Group Oncology, LLC Miami Florida 33176
Sarah Cannon Research Institution St. Petersburg Florida 33705
Palm Beach Cancer Institute West Palm Beach Florida 33401
Piedmont Cancer Institute, PC Atlanta Georgia 30318
Emory University/Winship Cancer Institute Atlanta Georgia 30322
Suburban Hematology-Oncology Associates, PC - Lawrenceville Lawrenceville Georgia 30046
Illinois Cancer Specialists Arlington Heights Illinois 60005
Northshore University Healthsystem Evanston Illinois 60201
Healthcare Research Network III, LLC Tinley Park Illinois 60487
Northwestern Medicine Cancer Center Warrenville Illinois 60555
Parkview Research Center Fort Wayne Indiana 46845
Indiana University Health Goshen Center for Cancer Care Goshen Indiana 46526
Michiana Hematology Oncology, PC Mishawaka Indiana 46545
Cancer Center of Kansas Wichita Kansas 67214
Dana Farber Boston Massachusetts 02215
Umass Memorial Medical Center Worcester Massachusetts 01655
University of Michigan Cancer Center Ann Arbor Michigan
Minnesota Oncology Hematology, P.A. Minneapolis Minnesota 55404
Mayo Clinic Arizona Rochester Minnesota 55905
Research Medical Center Kansas City Missouri 64132
Missouri Baptist Medical Center ACCRU Network Site St Louis Missouri 63131
Saint Francis Cancer Treatment Center Grand Island Nebraska 68803
Missouri Valley Cancer Consortium Omaha Nebraska 68106
Cancer Research Network of Nebraska / Oncology Associates PC Omaha Nebraska 68118
Tennessee Oncology PLLC Omaha Nebraska 68118
Darthmouth-Hitchcock Medical Center Lebanon New Hampshire 03756
Carol G. Simon Cancer Center Morristown New Jersey 07962
University of New Mexico Albuquerque New Mexico 87131
Roswell Park Cancer Center Buffalo New York 14263
North Shore Hematology Oncology Associates East Setauket New York 11733
Weill Cornell Medical College New York New York 10065
Montefiore Medical Center The Bronx New York 10467
Southeastern Medical Oncology Center Goldsboro North Carolina 27534
Wake Forest Baptist Medical Center Winston-Salem North Carolina 27157
Toledo Clinic Cancer Centers Toledo Ohio 43623
Geisinger Medical Center Danville Pennsylvania 17822
VA Pittsburgh Healthcare System Pittsburgh Pennsylvania 15240
Medical University of South Carolina Charleston South Carolina 29412
Sanford Cancer Center Sioux Falls South Dakota 57104
University of Tennessee Medical Center Knoxville Tennessee 37920
West Cancer Center Memphis Tennessee 38138
The Sarah Cannon Research Institute Nashville Tennessee 37203
Texas Oncology-Austin Midtown Austin Texas 75705
Texas Oncology - Dallas Center Dallas Texas 75203
Texas Oncology - Denton South Denton Texas 76210
Texas Oncology - Fort Worth Fort Worth Texas 76104
Millenium Oncology Houston Texas 77090
Texas Health Physicians Group Plano Texas 75093
Texas Oncology-San Antonio San Antonio Texas 78217
Texas Oncology - Tyler Tyler Texas 75702
Texas Oncology - Wichita Falls Texoma Cancer Center Wichita Falls Texas 76310
Northern Utah Associates Ogden Utah 84403
US Oncology - Virginia Cancer Specialists, PC Fairfax Virginia 22031
Fort Belvoir Community Hospital Fort Belvoir Virginia 22060
Virginia Oncology Associates Hampton Virginia 23666
Blue Ridge Cancer Care Roanoke Virginia 24014
Virginia Mason Seattle Washington 98101
Seattle Cancer Care Alliance Seattle Washington 98109-1023
Northwest Cancer Specialists, P.C. Vancouver Washington 98684

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 137 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02753127, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 14, 2023 · Synced May 14, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02753127 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →